GB9715759D0 - New emulsion formulations - Google Patents

New emulsion formulations

Info

Publication number
GB9715759D0
GB9715759D0 GBGB9715759.8A GB9715759A GB9715759D0 GB 9715759 D0 GB9715759 D0 GB 9715759D0 GB 9715759 A GB9715759 A GB 9715759A GB 9715759 D0 GB9715759 D0 GB 9715759D0
Authority
GB
United Kingdom
Prior art keywords
emulsion formulations
new emulsion
new
formulations
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9715759.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
Danbiosyst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst UK Ltd filed Critical Danbiosyst UK Ltd
Priority to GBGB9715759.8A priority Critical patent/GB9715759D0/en
Publication of GB9715759D0 publication Critical patent/GB9715759D0/en
Priority to EP98935215A priority patent/EP0999833A1/en
Priority to AU84561/98A priority patent/AU8456198A/en
Priority to PCT/GB1998/002220 priority patent/WO1999004787A1/en
Priority to ZA9806645A priority patent/ZA986645B/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB9715759.8A 1997-07-26 1997-07-26 New emulsion formulations Pending GB9715759D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9715759.8A GB9715759D0 (en) 1997-07-26 1997-07-26 New emulsion formulations
EP98935215A EP0999833A1 (en) 1997-07-26 1998-07-24 Taxol emulsion
AU84561/98A AU8456198A (en) 1997-07-26 1998-07-24 Taxol emulsion
PCT/GB1998/002220 WO1999004787A1 (en) 1997-07-26 1998-07-24 Taxol emulsion
ZA9806645A ZA986645B (en) 1997-07-26 1998-07-24 Emulsion.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9715759.8A GB9715759D0 (en) 1997-07-26 1997-07-26 New emulsion formulations

Publications (1)

Publication Number Publication Date
GB9715759D0 true GB9715759D0 (en) 1997-10-01

Family

ID=10816477

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9715759.8A Pending GB9715759D0 (en) 1997-07-26 1997-07-26 New emulsion formulations

Country Status (5)

Country Link
EP (1) EP0999833A1 (en)
AU (1) AU8456198A (en)
GB (1) GB9715759D0 (en)
WO (1) WO1999004787A1 (en)
ZA (1) ZA986645B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727280B2 (en) 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
DE19843968A1 (en) * 1998-09-24 2000-04-13 Hans Dietl Taxane-containing pharmaceutical preparation for intravenous administration and process for their preparation
AU4053700A (en) * 1999-04-02 2000-10-23 Washington State University Research Foundation Enhanced tissue and subcellular delivery of vitamin e compounds
EP1185301A1 (en) * 1999-05-24 2002-03-13 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
WO2001022937A1 (en) * 1999-09-27 2001-04-05 Sonus Pharmaceuticals, Inc. Compositions of tocol-soluble therapeutics
WO2002026208A2 (en) * 2000-09-27 2002-04-04 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
WO2002043765A2 (en) * 2000-11-28 2002-06-06 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
US6858227B1 (en) 2001-11-21 2005-02-22 Sonus Pharmaceuticals, Inc. Vitamin E conjugates
ES2283756T3 (en) * 2002-03-01 2007-11-01 Novagali Pharma Sa PHARMACO ADMINISTRATION ADMINISTRATION SYSTEMS FOR TAXOIDS.
EP1340497A1 (en) * 2002-03-01 2003-09-03 Novagali Sas Self emulsifying drug delivery systems for poorly soluble drugs
BRPI0415858A (en) * 2003-10-29 2007-01-09 Sonus Pharma Inc compounds of tocopherol-modified therapeutic drugs
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
EP1748759B1 (en) * 2004-04-27 2013-03-27 Javeri, Indu Methods of enhancing solubility in water of hydrophobic compounds by micellar dispersions
US8557861B2 (en) 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
TWI376239B (en) 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
WO2010018596A2 (en) 2008-07-23 2010-02-18 Bharat Serums And Vaccines Ltd. Stable injectable oil-in-water docetaxel nanoemulsion
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US9402812B2 (en) 2009-09-23 2016-08-02 Indu JAVERI Methods for the preparation of liposomes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL72420A (en) * 1983-07-22 1987-10-30 Hoffmann La Roche Aqueous vitamin e solutions and their manufacture
CA2033725C (en) * 1990-01-24 2001-05-29 Folker Pittrof Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
JPH06157294A (en) * 1992-11-19 1994-06-03 Tanabe Seiyaku Co Ltd Fine-granular fat preparation
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs

Also Published As

Publication number Publication date
AU8456198A (en) 1999-02-16
EP0999833A1 (en) 2000-05-17
WO1999004787A1 (en) 1999-02-04
ZA986645B (en) 2000-01-24

Similar Documents

Publication Publication Date Title
GB9715751D0 (en) Formulations
IL135295A0 (en) 2-methyl-thieno-benzodiazepine formulation
EP1020194A4 (en) O/w emulsion compositions
PL336840A1 (en) Hair-care composition
PL335870A1 (en) Hair-care composition
EP1049486A4 (en) Glp-1 formulations
EP0965328A4 (en) Cosmetic
ZA9811461B (en) New formulation
ZA984216B (en) Clear emulsion cosmetic compositions.
GB9715759D0 (en) New emulsion formulations
AU6119298A (en) Emulsion composition
PL345202A1 (en) W/o emulsion bases
ZA985669B (en) New formulation
GB9724544D0 (en) Novel Formulation
ZA9810184B (en) New phenyl-alkyl-imidazoles
EP0968655A4 (en) Spread
GB9722691D0 (en) Emulsion composition
GB9725061D0 (en) Revitalisation formulation
GB9706957D0 (en) Formulation
IL134408A0 (en) Anti-first- pass effect compounds
GB9704521D0 (en) Formulations
GB9703101D0 (en) Formulations
GB9703100D0 (en) Formulations
GB9703099D0 (en) Formulations
IL136525A0 (en) Agents